BOULDER, Colo., March 31, 2026 -- Ambrosia Biosciences Inc. (“Ambrosia”) today announced a $100 million oversubscribed Series B financing. The financing provides $100 million in committed capital, intended to fund the Company through clinical trial initiation of its oral small molecule GLP-1. The financing was co-led by new investors Blue Owl Healthcare Opportunities, Redmile and Deep Track Capital. Existing investors BVF Partners and Boulder Ventures also participated, and were joined by additional new investors Janus Henderson Investors, Samsara BioCapital, and an undisclosed institutional investor.
Read MoreIn 2025, the AMGA commenced a 5-year strategic plan that will provide direction and focus for the organization through 2029. The plan drives mission-driven initiatives that will increase public land access for guides, advertise the value of AMGA training and certification to the public, review and evaluate AMGA risk management practices, improve accessibility to AMGA courses and exams, establish financial practices that support long-term AMGA financial health, and modernize AMGA Mountain Guide Program curriculum and educational practices to meet the evolving needs of students.
Read MoreFebruary 18, 2026|Denver, CO—Comeryx, an AI-native, fully digital Managing General Agent (MGA), today announced its formation and the closing of a $7.5 million funding round. The investment was led by Altai Ventures, with participation from American Family Ventures, Intact Ventures, Boulder Ventures, Arch Capital Group Ltd., and Echelon.
Read MoreSAN FRANCISCO--(BUSINESS WIRE)--RapidFort, the technical leader defining the next generation of software supply chain security, today announced $42 million in Series A funding led by Blue Cloud Ventures and Forgepoint Capital, with participation from prior lead investor Felicis Ventures. Additional participants include Alumni Ventures, Boulder Ventures, Brave Capital, Evolution Ventures, Florida Funders, Gaingels, and Mana Ventures. Read more here.
Read MoreBoulder, CO and Austin, TX —Althea, a public benefit company building infrastructure for regulated psychedelic therapy, today announced its acquisition of Tricycle Day, the leading independent newsletter focused on psychedelic education.
The acquisition brings together two complementary efforts working toward the same goal: helping people responsibly find their way to psychedelic care. Althea provides compliance, payments, and care-navigation software for licensed facilitators and centers operating in state-regulated programs, while Tricycle Day has built one of the most trusted audiences for thoughtful, accessible psychedelic education.
Read MoreAIARE was created to solve a serious problem.
When my partners Jean Pavillard, Karl Klassen, and I co-founded AIARE in 1998, the number of avalanche fatalities each season in the United States had begun to climb drastically. Just a couple of years before, a sidecounty avalanche at a resort in our home state of Colorado resulted in multiple burials and four people dead—four families and an entire community grieving. Sadly, a version of this story was repeated numerous times in the mountains each winter.
Read MoreTYSONS CORNER, Va., Dec. 3, 2025 /PRNewswire/ -- Antithesis today announced a $105 million Series A round led by Jane Street, the global technology-driven quantitative trading firm known for building some of the world's most advanced software systems. The investment underscores Antithesis's emergence as critical infrastructure for enterprises operating complex, distributed systems. Jane Street is both an Antithesis investor and customer.
Read MoreSteve House sits down with Kyle Lefkoff, a rare figure who has lived at the intersection of serious alpinism and venture capital for nearly four decades. From discovering his "mutant gene" for rock climbing as a kid in Atlanta to surviving K2's deadliest season in 1986, from co-founding Array Biopharma (acquired by Pfizer for $12 billion) to serving as founding chairman of AIARE, Kyle shares how the same principles—luck, timing, patience, and pattern recognition—govern success on both big walls and in boardrooms.
Read MoreSince the dawn of Middle Earth, it has been somewhat widely accepted that it takes 8-10 years to build a real database. There’s a lot that has to go right; databases need to be rock solid. They need to be battle tested, consistent, fault tolerant, and most of all, trustworthy. These are things that take time to dial in.
But in 2009 a small team of childhood friends in Virginia somehow broke the rule. In a few short years the Daves (Rosenthal and Scherer) and Nick built something that everyone said they couldn’t: a distributed storage engine with ACID guarantees. It was called FoundationDB, it took the world by storm, and then it got acquired in 2015 by Apple (you can still download and use it here).
Read More